Meridian Bioscience Inc
Diagnostics & Research
Healthcare
VIVO
44.26 M shares
NASDAQ US
traded
30 Jan 2023
listed
yes
open
33.95
52 week high
33.97
high
34.01
52 week low
20.43
previous Close
33.97
P/E ratio
market cap
1.35 B
div yield
0
net incoming
28.75 M
87.43 %
net profit margin
25.85 %
8.00 %
operating incoming
36.14 M
78.18 %
net change in cash
3.76 M
-83.63 %
cash on hand
76.49 M
5.17 %
cost of revenue
42.75 M
9.12 %
top